Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 2
1970 1
1971 1
1972 2
1973 1
1975 3
1978 1
1979 1
1980 1
1982 1
1983 2
1984 2
1985 4
1986 1
1987 5
1988 6
1989 4
1990 3
1991 7
1992 4
1993 8
1994 8
1995 5
1996 4
1997 12
1998 6
1999 13
2000 11
2001 12
2002 5
2003 5
2004 7
2005 6
2006 1
2007 5
2008 3
2009 4
2010 4
2011 7
2012 8
2013 9
2014 7
2015 5
2016 6
2017 4
2018 3
2019 3
2020 5
2021 8
2022 6
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

235 results

Results by year

Filters applied: . Clear all
Page 1
Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer.
Wadensten E, Wessman S, Abel F, Diaz De Ståhl T, Tesi B, Orsmark Pietras C, Arvidsson L, Taylan F, Fransson S, Vogt H, Poluha A, Pradhananga S, Hellberg M, Lagerstedt-Robinson K, Raj Somarajan P, Samuelsson S, Orrsjö S, Maqbool K, Henning K, Strid T, Ek T, Fagman H, Olsson Bontell T, Martinsson T, Puls F, Kogner P, Wirta V, Pronk CJ, Wille J, Rosenquist R, Nistér M, Mertens F, Sabel M, Norén-Nyström U, Grillner P, Nordgren A, Ljungman G, Sandgren J, Gisselsson D; Genomic Medicine Sweden Childhood Cancer Working Group. Wadensten E, et al. Among authors: martinsson t. JCO Precis Oncol. 2023 Jun;7:e2300039. doi: 10.1200/PO.23.00039. JCO Precis Oncol. 2023. PMID: 37384868 Free PMC article.
METTL3 drives telomere targeting of TERRA lncRNA through m6A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma.
Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, Lundberg KI, Bartenhagen C, Kumar N, Tümmler C, Sihlbom C, Fransson S, Johnsen JI, Kogner P, Martinsson T, Fischer M, Mondal T. Vaid R, et al. Among authors: martinsson t. Nucleic Acids Res. 2024 Mar 21;52(5):2648-2671. doi: 10.1093/nar/gkad1242. Nucleic Acids Res. 2024. PMID: 38180812 Free PMC article.
Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup.
Martinez-Monleon A, Kryh Öberg H, Gaarder J, Berbegall AP, Javanmardi N, Djos A, Ussowicz M, Taschner-Mandl S, Ambros IM, Øra I, Sandstedt B, Beiske K, Ladenstein R, Noguera R, Ambros PF, Gordon Murkes L, Ljungman G, Kogner P, Fransson S, Martinsson T. Martinez-Monleon A, et al. Among authors: martinsson t. Sci Rep. 2022 Jul 20;12(1):12420. doi: 10.1038/s41598-022-16455-1. Sci Rep. 2022. PMID: 35859155 Free PMC article.
Rho-associated kinase is a therapeutic target in neuroblastoma.
Dyberg C, Fransson S, Andonova T, Sveinbjörnsson B, Lännerholm-Palm J, Olsen TK, Forsberg D, Herlenius E, Martinsson T, Brodin B, Kogner P, Johnsen JI, Wickström M. Dyberg C, et al. Among authors: martinsson t. Proc Natl Acad Sci U S A. 2017 Aug 8;114(32):E6603-E6612. doi: 10.1073/pnas.1706011114. Epub 2017 Jul 24. Proc Natl Acad Sci U S A. 2017. PMID: 28739902 Free PMC article.
PPM1D Is a Therapeutic Target in Childhood Neural Tumors.
Milosevic J, Treis D, Fransson S, Gallo-Oller G, Sveinbjörnsson B, Eissler N, Tanino K, Sakaguchi K, Martinsson T, Wickström M, Kogner P, Johnsen JI. Milosevic J, et al. Among authors: martinsson t. Cancers (Basel). 2021 Nov 30;13(23):6042. doi: 10.3390/cancers13236042. Cancers (Basel). 2021. PMID: 34885154 Free PMC article.
235 results